Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 6 | Clinical Proteomics

Fig. 6

From: Distinct proteome pathology of circulating microparticles in systemic lupus erythematosus

Fig. 6

Specific metabolic profile of SLE-MPs. Simplified diagrams of pathways with box plots (medians and interquartile ranges, whiskers at 10–90 percentiles; red SLE; blue HC) of the intensities of 15 specific enzymes inserted. PGI, phosphoglucose isomerase; 6-PFK, 6-phosphofructokinase; Aldol., transaldolase; GAPD, glyceraldehyde-3-phosphate dehydrogenase; PGM, Phosphoglycerate mutase; αENO, alpha-enolase; PK, Pyruvate kinase; LDH, lactate dehydrogenase; PDH, pyruvate dehydrogenase; CiS, citrate synthase; ACON, aconitase; MDH, Malate dehydrogenase; G6PD, Glucose-6-phosphate dehydrogenase; PGD, 6-phosphogluconate dehydrogenase; TK, transketolase. All differences between SLE and HC are highly significant (q < 0.002, Mann–Whitney, two-tailed, Benjamini–Hochberg adjusted)

Back to article page